Cited by 477Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingDeep Brain Stimulation and Movement Disorders

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Parkin-deficient mice are not a robust model of parkinsonism

Open access

Perez, Francisco A., Palmiter, Richard D.·2005·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.0409598102PMC PMC548311

Open this paper in CoChat — free account

Abstract

Mutations in the human parkin gene cause autosomal recessive juvenile parkinsonism, a heritable form of Parkinson's disease (PD). To determine whether mutations in the mouse parkin gene ( Park2 ) also result in a parkinsonian phenotype, we generated mice with a targeted deletion of parkin exon 2. Using an extensive behavioral screen, we evaluated neurological function, motor ability, emotionality, learning, and memory in aged Parkin-deficient mice. The behavioral profile of Parkin-deficient mice on a B6;129S4 genetic background was strikingly similar to that of control mice, and most differences were not reproducible by using coisogenic mice on a 129S4 genetic background. Moreover, catecholamine levels in the striatum, olfactory bulb, and spinal cord of Parkin-deficient mice were normal. In contrast to previous studies using independently generated Parkin-deficient mice, we found no evidence for nigrostriatal, cognitive, or noradrenergic dysfunction. Understanding why Parkin-deficient mice do not exhibit robust signs of parkinsonism could advance knowledge and treatment of PD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.0409598102

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Controlling the false discovery rate in behavior genetics research
Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N., & Golani, I. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00297-2 · Cited by 4,146
Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401135200 · Cited by 995
Parkin functions as an E2-dependent ubiquitin– protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1
Zhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982
Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons
Goldberg, M. S., Fleming, S. M., Palacino, J. J., Cepeda, C., Lam, H. A., Bhatnagar, A., Meloni, E. G., Wu, N., Ackerson, L. C., Klapstein, G. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308947200 · Cited by 913
Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?
Gerlai, R. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)20020-7 · Cited by 881
Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment
Rogers, D. C., Fisher, E. M. C., Brown, S. D. M., Peters, J., Hunter, A. J., & Martin, J. E. (1997) · Mammalian Genome · doi:10.1007/s003359900551 · Cited by 795
Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity
Imai, Y., Soda, M., & Takahashi, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000447200 · Cited by 766
Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice
Simpson, E. M., Linder, C. C., Sargent, E. E., Davisson, M. T., Mobraaten, L. E., & Sharp, J. J. (1997) · Nature Genetics · doi:10.1038/ng0597-19 · Cited by 684

Show all 45 references

Research works printed but not linked: 3

Schrag, A. (2004) J. Neurol. 251, 795-804.15258780
Ralph, R. J., Paulus, M. P. & Geyer, M. A. (2001) J. Pharmacol. Exp. Ther. 298, 148-155.11408536
Flaherty, L. (1981) in The Mouse in Biomedical Research, eds. Foster, H. L., Small, J. D. & Fox, J. G. (Academic, New York), Vol. 1, pp. 215-222.

Sorted by citations

Items 201–300 of 475

Genetic Mouse Models of Neurodegenerative Diseases
Trancikova, A. K., Ramonet, D., & Moore, D. J. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-384878-9.00012-1 · Cited by 47
Deletion of GAD67 in dopamine receptor‐1 expressing cells causes specific motor deficits
Heusner, C. L., Beutler, L. R., Houser, C. R., & Palmiter, R. D. (2008) · genesis · doi:10.1002/dvg.20405 · Cited by 47
Self-citation
Genetically modified large animal models for investigating neurodegenerative diseases
Yang, W., Chen, X., Li, S., & Li, X.-J. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00729-8 · Cited by 45
MITOL promotes cell survival by degrading Parkin during mitophagy
Shiiba, I., Takeda, K., Nagashima, S., Ito, N., Tokuyama, T., Yamashita, S., Kanki, T., Komatsu, T., Urano, Y., Fujikawa, Y., et al. (2021) · EMBO Reports · doi:10.15252/embr.201949097 · Cited by 45
Modeling Parkinson's disease
Olanow, C. W., & Kordower, J. H. (2009) · Annals of Neurology · doi:10.1002/ana.21832 · Cited by 45
Parkin Protects Against Misfolded SOD1 Toxicity by Promoting Its Aggresome Formation and Autophagic Clearance
Yung, C., Di, S., Li, L., & Chin, L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9537-z · Cited by 45
Parkin elimination of mitochondria is important for maintenance of lens epithelial cell ROS levels and survival upon oxidative stress exposure
Brennan, L., Khoury, J., & Kantorow, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.09.020 · Cited by 45
Intrarenal Dopamine Inhibits Progression of Diabetic Nephropathy
Zhang, M., Yao, B., Yang, S., Yang, H., Wang, S., Fan, X., Yin, H., Fogo, A. B., Moeckel, G. W., & Harris, R. C. (2012) · Diabetes · doi:10.2337/db12-0046 · Cited by 44
Mitophagy and Neurodegeneration: Between the Knowns and the Unknowns
Jetto, C. T., Nambiar, A., & Manjithaya, R. R. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.837337 · Cited by 44
Parkin maintains mitochondrial levels of the protective Parkinson’s disease-related enzyme 17-β hydroxysteroid dehydrogenase type 10
Bertolin, G., Jacoupy, M., Traver, S., Ferrando-Miguel, R., Georges, T. S., Grenier, K., Ardila-Osorio, H., Mp, M., Takahashi, H., Lees, A. J., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2014.224 · Cited by 45
Mitophagy in Neurons: Mechanisms Regulating Mitochondrial Turnover and Neuronal Homeostasis
Basak, B., & Holzbaur, E. L. F. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169161 · Cited by 44
What have we learned from Drosophila models of Parkinson’s disease?
Guo, M. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84001-4 · Cited by 44
Loss-of-Function Rodent Models for Parkin and PINK1
Oliveras-Salvá, M., Rompuy, A. V., Heeman, B., den Haute, C. V., & Baekelandt, V. (2011) · Journal of Parkinson s Disease · doi:10.3233/jpd-2011-11041 · Cited by 44
Genetic modifiers of neurological disease
Kearney, J. A. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.12.007 · Cited by 43
Contributions of signaling by dopamine neurons in dorsal striatum to cognitive behaviors corresponding to those observed in Parkinson's disease
Darvas, M., Henschen, C. W., & Palmiter, R. D. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.01.017 · Cited by 45
Self-citation
Neuronal firing patterns outweigh circuitry oscillations in parkinsonian motor control
Pan, M., Kuo, S., Tai, C., Liou, J.-Y., Pei, J.-C., Chang, C., Wang, Y., Liu, W.-C., Wang, T.-R., Lai, W., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci88170 · Cited by 46
Modeling Parkinson’s Disease Using Patient-specific Induced Pluripotent Stem Cells
Li, H., Jiang, H., Zhang, B., & Feng, J. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181353 · Cited by 44
Genetic factors involved in the pathogenesis of Parkinson's disease
Lee, F. J. S., & Liu, F. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.02.001 · Cited by 43
RNA knockdown as a potential therapeutic strategy in Parkinson's disease
Manfredsson, F. P., Lewin, A. S., & Mandel, R. J. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302669 · Cited by 43
Deletion of theparkinandPACRGgene promoter in early-onset parkinsonism
Lesage, S., Periquet, M., Lohmann, E., Lacomblez, L., Teive, H. A. G., Janin, S., Cousin, P.-Y., Dürr, A., Brice, A., & for the French Parkinson Disease Genetics Study Group (2006) · Human Mutation · doi:10.1002/humu.20436 · Cited by 43
Parkinson's disease, proteins, and prions: Milestones
Olanow, C. W., & McNaught, K. S. P. (2011) · Movement Disorders · doi:10.1002/mds.23767 · Cited by 43
PINK1-Parkin signaling in Parkinson’s disease: Lessons from Drosophila
Imai, Y. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.01.016 · Cited by 42
Genetic Mapping of Canine Multiple System Degeneration and Ectodermal Dysplasia Loci
O’Brien, D. P. (2005) · Journal of Heredity · doi:10.1093/jhered/esi086 · Cited by 41
Enhanced vulnerability of PARK6 patient skin fibroblasts to apoptosis induced by proteasomal stress
Klinkenberg, M., Thurow, N., Gispert, S., Ricciardi, F., Eich, F., Prehn, J. H. M., Auburger, G. W. J., & Kögel, D. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2009.12.068 · Cited by 41
Role of Mitochondrial Nucleic Acid Sensing Pathways in Health and Patho-Physiology
Chowdhury, A., Witte, S., & Aich, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.796066 · Cited by 40
Comprehensive Perspectives on Experimental Models for Parkinson’s Disease
Ke, M., Chong, C., Zhu, Q., Zhang, K., Cai, C.-Z., Lu, J., Qin, D., & Su, H. (2021) · Aging and Disease · doi:10.14336/ad.2020.0331 · Cited by 41
The “mitochondrial stress responses”: the “Dr. Jekyll and Mr. Hyde” of neuronal disorders
Rimessi, A., Patergnani, S., Morciano, G., Carinci, M., Leo, S., & Pinton, P. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.339473 · Cited by 41
Therapeutic strategies in Parkinson's disease: what we have learned from animal models
Valadas, J. S., Vos, M. H., & Verstreken, P. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12577 · Cited by 44
Gene and protein signatures in sporadic Parkinson's disease and a novel genetic model of PD
Mandel, S. A., Fishman-Jacob, T., & Youdim, M. B. H. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70009-9 · Cited by 38
Genetic suppression of IKK2/NF-κB in astrocytes inhibits neuroinflammation and reduces neuronal loss in the MPTP-Probenecid model of Parkinson's disease
Kirkley, K. S., Popichak, K. A., Hammond, S. L., Davies, C., Hunt, L. G., & Tjalkens, R. B. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.02.020 · Cited by 37
The role of mitophagy during oocyte aging in human, mouse, and Drosophila: implications for oocyte quality and mitochondrial disease
Cox, R. T., Poulton, J., & Williams, S. A. (2021) · Reproduction and Fertility · doi:10.1530/raf-21-0060 · Cited by 37
Downstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia: From experimental models to neurodegenerative diseases
Gubellini, P., Picconi, B., Filippo, M. D., & Calabresi, P. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.001 · Cited by 40
Neuronal Preconditioning Requires the Mitophagic Activity of C-terminus of HSC70-Interacting Protein
Lizama, B. N., Palubinsky, A. M., Raveendran, V. A., Moore, A. M., Federspiel, J. D., Codreanu, S. G., Liebler, D. C., & McLaughlin, B. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0699-18.2018 · Cited by 37
Differential effects of l ‐DOPA on monoamine metabolism, cell survival and glutathione production in midbrain neuronal‐enriched cultures from parkin knockout and wild‐type mice
Casarejos, M. J., Solano, R. M., Menéndez, J., Rodríguez‐Navarro, J. A., Correa, C., de Yébenes, J. G., & Mena, M. A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03249.x · Cited by 37
Selective Neuron Vulnerability in Common and Rare Diseases—Mitochondria in the Focus
Paß, T., Wiesner, R. J., & Pla‐Martín, D. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.676187 · Cited by 37
RBR Ubiquitin Ligases: Diversification and Streamlining in Animal Lineages
Marı́n, I. (2009) · Journal of Molecular Evolution · doi:10.1007/s00239-009-9252-3 · Cited by 38
Increasing the Coding Potential of Genomes Through Alternative Splicing: The Case of PARK2 Gene
Cognata, V. L., Iemmolo, R., D’Agata, V., Scuderi, S., Drago, F., Zappia, M., & Cavallaro, S. (2014) · Current Genomics · doi:10.2174/1389202915666140426003342 · Cited by 37
The STING pathway does not contribute to behavioural or mitochondrial phenotypes in Drosophila Pink1/parkin or mtDNA mutator models
Lee, J. J., Andreazza, S., & Whitworth, A. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-59647-3 · Cited by 36
Mitochondrial Aging in the CNS: Unravelling Implications for Neurological Health and Disease
Steffan, D., Pezzini, C., Esposito, M., & Franco‐Romero, A. (2025) · Biomolecules · doi:10.3390/biom15091252 · Cited by 37
Cross-species models of attention-deficit/hyperactivity disorder and autism spectrum disorder
Vecchia, E. D., Mortimer, N., Palladino, V. S., Kittel‐Schneider, S., Lesch, K., Reif, A., Schenck, A., & Norton, W. (2018) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000211 · Cited by 36
The neuronal ubiquitin-proteasome system: Murine models and their neurological phenotype
van Tijn, P., Hol, E. M., van Leeuwen, F. W., & Fischer, D. F. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.03.001 · Cited by 35
Mitophagy in Parkinson's disease: From pathogenesis to treatment target
Dernie, F. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104756 · Cited by 33
GDNF/RET signaling in dopamine neurons in vivo
Conway, J. A., Ince, S., Black, S., & Kramer, E. R. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03268-9 · Cited by 33
Differences in aggressive behavior and in the mesocorticolimbic DA system between A/J and BALB/cJ mice
Couppis, M. H., Kennedy, C. H., & Stanwood, G. D. (2008) · Synapse · doi:10.1002/syn.20545 · Cited by 33
Pathologic and therapeutic implications for the cell biology of parkin
Charan, R. A., & LaVoie, M. J. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.02.008 · Cited by 32
Severely Impaired Learning and Altered Neuronal Morphology in Mice Lacking NMDA Receptors in Medium Spiny Neurons
Beutler, L. R., Eldred, K. C., Quintana, A., Keene, C. D., Rose, S. E., Postupna, N. O., Montine, T. J., & Palmiter, R. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028168 · Cited by 32
Self-citation
The role of KATP channel blockade and activation in the protection against neurodegeneration in the rotenone model of Parkinson's disease
Abdelkader, N. F., Farid, H. A., Youness, E. R., Abdel‐Salam, O. M. E., & Zaki, H. F. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118070 · Cited by 32
Mitochondrial Pathobiology in Parkinson's Disease and Amyotrophic Lateral Sclerosis
Martin, L. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100348 · Cited by 32
Clec16a is Critical for Autolysosome Function and Purkinje Cell Survival
Redmann, V., Lamb, C. A., Hwang, S., Orchard, R. C., Kim, S., Razi, M., Milam, A., Park, S., Yokoyama, C. C., Kambal, A., et al. (2016) · Scientific Reports · doi:10.1038/srep23326 · Cited by 31
Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease
Hennis, M. R., Marvin, M. A., Taylor, C. M., & Goldberg, M. S. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.009 · Cited by 31
Interfaces between mitochondrial dynamics and disease
Mishra, P. (2016) · Cell Calcium · doi:10.1016/j.ceca.2016.05.004 · Cited by 32
Ubiquitination at the mitochondria in neuronal health and disease
Covill‐Cooke, C., Howden, J. H., Birsa, N., & Kittler, J. T. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.07.003 · Cited by 33
Low-level laser therapy modulates demyelination in mice
Duarte, K. C. N., Soares, T. T., Magri, A. M. P., Garcia, L. A., Sueur, L. D. P. L., Rennó, A. C. M., & de Castro, G. M. (2018) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2018.09.024 · Cited by 32
Hidden phenotypes of PINK1/Parkin knockout mice
Paul, S., & Pickrell, A. M. (2021) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2021.129871 · Cited by 31
Microbes and Parkinson’s disease: from associations to mechanisms
Cannon, T., & Gruenheid, S. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.01.004 · Cited by 33
Roles of microglial mitophagy in neurological disorders
Liu, Y., Wang, M., Hou, X., & Hu, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.979869 · Cited by 31
Integrated pathways of parkin control over mitochondrial maintenance – relevance to Parkinson’s disease pathogenesis
Gawęda-Walerych, K., & Żekanowski, C. (2013) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2013-1931 · Cited by 30
Amyloid-like oligomerization of AIMP2 contributes to α-synuclein interaction and Lewy-like inclusion
Ham, S., Yun, S. P., Kim, H., Kim, D., Seo, B. A., Kim, H., Shin, J., Dar, M. A., Lee, G. H., Lee, Y. I., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax0091 · Cited by 30
Behavioral analysis of motor and non-motor impairment in rodent models of Parkinson's disease
Sheta, R., Bérard, M., Musiol, D., Martínez-Drudis, L., & Oueslati, A. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1464706 · Cited by 26
Culprit or Bystander: Defective Mitophagy in Alzheimer’s Disease
Xie, C., Aman, Y., Adriaanse, B. A., Cader, M. Z., Plun‐Favreau, H., Xiao, J., & Fang, E. F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00391 · Cited by 29
CHIP Is an Essential Determinant of Neuronal Mitochondrial Stress Signaling
Palubinsky, A. M., Stankowski, J. N., Kale, A. C., Codreanu, S. G., Singer, R. J., Liebler, D. C., Stanwood, G. D., & McLaughlin, B. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6102 · Cited by 29
Dopamine Induces Oscillatory Activities in Human Midbrain Neurons with Parkin Mutations
Zhong, P., Hu, Z., Jiang, H., Yan, Z., & Feng, J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.023 · Cited by 29
Outlook of PINK1/Parkin signaling in molecular etiology of Parkinson’s disease, with insights into Pink1 knockout models
Wang, Z., Chan, S.-W., Zhao, H., Miu, K.-K., & Chan, W. (2023) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2022.406 · Cited by 28
Exploring the Role of Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease
Zhao, Y., Lin, M., Zhai, F., Chen, J., & Jin, X. (2024) · Pharmaceuticals · doi:10.3390/ph17060782 · Cited by 29
Therapy for hyperthermia-induced seizures in Scn1a mutant rats
Hayashi, K., Ueshima, S., Ouchida, M., Mashimo, T., Nishiki, T., Sendo, T., Serikawa, T., Matsui, H., & Ohmori, I. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03046.x · Cited by 28
Parkin potentiates ATP‐induced currents due to activation of P2X receptors in PC12 cells
Sato, A., Arimura, Y., Manago, Y., Nishikawa, K., Aoki, K., Wada, E., Suzuki, Y., Osaka, H., Setsuie, R., Sakurai, M., et al. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20719 · Cited by 28
Stem cells and the treatment of Parkinson's disease
Ali, F. R., Stott, S., & Barker, R. A. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.12.017 · Cited by 29
Mitophagy and Neuroinflammation: A Compelling Interplay
Charmpilas, N., Fang, E. F., & Palikaras, K. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220628153632 · Cited by 27
Parkin interacts with Klokin1 for mitochondrial import and maintenance of membrane potential
Kuroda, Y., Sako, W., Goto, S., Sawada, T., Uchida, D., Izumi, Y., Takahashi, T., Kagawa, N., Matsumoto, M., Matsumoto, M., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr530 · Cited by 28
Mitochondrial Acetylation and Genetic Models of Parkinson's Disease
Auburger, G. W. J., Gispert, S., & Jendrach, M. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394625-6.00006-4 · Cited by 27
1‐Benzyl‐1,2,3,4‐tetrahydroisoquinoline binds with tubulin β, a substrate of parkin, and reduces its polyubiquitination
Kohta, R., Kotake, Y., Hosoya, T., Hiramatsu, T., Otsubo, Y., Koyama, H., Hirokane, Y., Yokoyama, Y., Ikeshoji, H., Oofusa, K., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06576.x · Cited by 26
How Well Do Rodent Models of Parkinson’s Disease Recapitulate Early Non-Motor Phenotypes? A Systematic Review
Zhang, T. D., Kolbe, S., Beauchamp, L. C., Woodbridge, E., Finkelstein, D. I., & Burrows, E. L. (2022) · Biomedicines · doi:10.3390/biomedicines10123026 · Cited by 25
Haploinsufficiency of the E3 Ubiquitin Ligase C-Terminus of Heat Shock Cognate 70 Interacting Protein (CHIP) Produces Specific Behavioral Impairments
McLaughlin, B., Buendia, M. A., Saborido, T. P., Palubinsky, A. M., Stankowski, J. N., & Stanwood, G. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036340 · Cited by 25
Mouse models of Parkinson's disease associated with mitochondrial dysfunction
Pickrell, A. M., Pinto, M., & Moraes, C. T. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.08.002 · Cited by 27
Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study
Caccappolo, E., Alcalay, R. N., Mejia‐Santana, H., Tang, M., Rakitin, B. C., Rosado, L., Louis, E. D., Comella, C. L., Colcher, A., Jennings, D. L., et al. (2010) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617710001190 · Cited by 25
Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling
Hu, Z., Pu, J., Jiang, H., Zhong, P., Qiu, J., Li, F., Wang, X., Zhang, B., Yan, Z., & Feng, J. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0079 · Cited by 25
PICK1 inhibits the E3 ubiquitin ligase activity of Parkin and reduces its neuronal protective effect
He, J., Xia, M., Yeung, P. K. K., Li, J., Li, Z., Chung, K. K. K., Chung, S. K., & Xia, J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716506115 · Cited by 25
Mitophagy
MacVicar, T. (2013) · Essays in Biochemistry · doi:10.1042/bse0550093 · Cited by 27
Medaka Fish Parkinson's Disease Model
Matsui, H., Gavinio, R., & Takahashi, R. (2012) · Experimental Neurobiology · doi:10.5607/en.2012.21.3.94 · Cited by 24
Neuroprotection by Endoplasmic Reticulum Stress-Induced HRD1 and Chaperones: Possible Therapeutic Targets for Alzheimer’s and Parkinson’s Disease
Nomura, J., Hosoi, T., Kaneko, M., Ozawa, K., Nishi, A., & Nomura, Y. (2016) · Medical Sciences · doi:10.3390/medsci4030014 · Cited by 23
Understanding the importance of autophagy in human diseases using Drosophila
Bhattacharjee, A., Szabó, Á., Csizmadia, T., Laczkó‐Dobos, H., & Juhász, G. (2019) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.03.007 · Cited by 23
Animal Models of Parkinson’s Disease
Blesa, J., Trigo‐Damas, I., Quiroga‐Varela, A., & del Rey, N. L. (2016) · InTech eBooks · doi:10.5772/63328 · Cited by 24
Mitophagy in the aging nervous system
Rappe, A., & McWilliams, T. G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.978142 · Cited by 22
Mitophagy and long-term neuronal homeostasis
Markaki, M., Tsagkari, D., & Tavernarakis, N. (2023) · Journal of Cell Science · doi:10.1242/jcs.260638 · Cited by 22
Redefining Parkinson’s Disease Research Using Induced Pluripotent Stem Cells
Pu, J., Jiang, H., Zhang, B., & Feng, J. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0288-1 · Cited by 22
One Step Into the Future: New iPSC Tools to Advance Research in Parkinson’s Disease and Neurological Disorders
Mohamed, N., Larroquette, F., Beitel, L. K., Fon, E. A., & Durcan, T. M. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-181515 · Cited by 23
Role of Mitochondrial Dysfunction in Parkinson???s Disease
Ramsey, C. P., & Giasson, B. I. (2007) · Drugs & Aging · doi:10.2165/00002512-200724020-00002 · Cited by 22
Transgenic Mouse Models for the Study of Neurodegenerative Diseases
Marín‐Moreno, A., Canoyra, S., Fernández‐Borges, N., Espinosa, J. C., & Torres, J. M. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2801021 · Cited by 21
Protein quality control in the endoplasmic reticulum
Koenig, P.-A., & Ploegh, H. L. (2014) · F1000Prime Reports · doi:10.12703/p6-49 · Cited by 21
Mitochondrial antigen presentation: a mechanism linking Parkinson’s disease to autoimmunity
Fahmy, A. M., Boulais, J., Desjardins, M., & Matheoud, D. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.02.004 · Cited by 22
Altered Hippocampal Synaptic Physiology in Aged Parkin-Deficient Mice
Hanson, J. E., Orr, A., & Madison, D. V. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8113-y · Cited by 21
Behavioral and Neurotransmitter Abnormalities in Mice Deficient for Parkin, DJ-1 and Superoxide Dismutase
Hennis, M. R., Seamans, K. W., Marvin, M. A., Casey, B. H., & Goldberg, M. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084894 · Cited by 21
Adhesion Molecule L1 Agonist Mimetics Protect Against the Pesticide Paraquat-Induced Locomotor Deficits and Biochemical Alterations in Zebrafish
Joseph, T. P., Jagadeesan, N., Sai, L., Lin, S. L., Sahu, S. S., & Schachner, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00458 · Cited by 20
Mitochondrial proteotoxicity: implications and ubiquitin-dependent quality control mechanisms
Karbowski, M., Oshima, Y., & Verhoeven, N. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04604-8 · Cited by 21
Role of epoxyeicosatrienoic acids (EETs) in mediation of dopamine's effects in the kidney
Zhang, M., Wang, Y., Yao, B., Gewin, L. S., Wei, S. D., Capdevila, J. H., & Harris, R. C. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00409.2013 · Cited by 20
Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons
Yokota, M., Kakuta, S., Shiga, T., Ishikawa, K., Okano, H., Hattori, N., Akamatsu, W., & Koike, M. (2021) · Molecular Brain · doi:10.1186/s13041-021-00771-0 · Cited by 23
Studies of Depression-Related States in Animal Models of Parkinsonism
Schintu, N., Zhang, X., & Svenningsson, P. (2012) · Journal of Parkinson s Disease · doi:10.3233/jpd-2012-12076 · Cited by 21
Proteomic studies associated with Parkinson’s disease
Kasap, M., Akpınar, G., & Kanlı, A. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1291344 · Cited by 20
Prkn knockout mice show autistic-like behaviors and aberrant synapse formation
Huo, Y., Lü, W., Tian, Y., Hou, Q., & Man, H. (2022) · iScience · doi:10.1016/j.isci.2022.104573 · Cited by 19
The Absence of Parkin Does Not Promote Dopamine or Mitochondrial Dysfunction in PolgAD257A/D257AMitochondrial Mutator Mice
Scott, L., Karuppagounder, S. S., Neifert, S., Kang, B. G., Wang, H., Dawson, V. L., & Dawson, T. M. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0545-22.2022 · Cited by 19

Authors: Perez, F. A., & Palmiter, R. D.
Affiliations: Howard Hughes Medical Institute (US)
ORCID: Perez, Francisco A.
Palmiter, Richard D.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2005-01-31
Volume: 102
Issue: 6
Pages: 2174-2179
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0409598102
PMC: PMC548311
OpenAlex: W2129698492
Cited by: 477
References: 45
Citations by year: 2026: 6 · 2025: 9 · 2024: 18 · 2023: 18 · 2022: 31 · 2021: 33 · 2020: 29 · 2019: 18 · 2018: 24 · 2017: 18 · 2016: 19 · 2015: 17 · 2014: 26 · 2013: 21 · 2012: 27
FWCI: 19.69
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Keywords: Parkin, PARK2, juvenile parkinsonism, autosomal recessive juvenile parkinsonism, Parkinson's disease, exon 2 deletion, behavioral phenotypes, motor function, emotionality, learning and memory, catecholamine levels, noradrenergic dysfunction, genetic background effects, B6
MeSH terms: Amphetamines, Animals, Behavior, Animal, Disease Models, Animal, Emotions, Genotype, Humans, Learning, Memory, Mice, Inbred C57BL, Motor Activity, Nerve Tissue, Parkinson Disease, Phenotype, Mice, Knockout, Ubiquitin-Protein Ligases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Parkin-deficient mice are not a robust model of parkinsonism

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks